Cogent Biosciences Stock Soars: A Year of Gains and a $4.5M Sell
Cogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
It's never too early to start thinking about retirement. Learn when and how to begin planning for a secure financial future.
13,704 articlesCogent Biosciences has delivered staggering gains in a single year, yet a major fund recently trimmed its stake by mi...
As migration reshapes the housing map, realtor.com’s 2026 forecast suggests certain markets will lead in affordabilit...
Investing in rare earths is a long game tied to U.S. policy, global demand, and the pace of production. This guide co...
A broad pullback in software stocks has created compelling opportunities for patient investors. Here are two names wi...
As the week nears its end, Thursday often brings a fresh wave of data and earnings that can move markets. This guide ...
Investors want to know if now is the time figma stock? This guide breaks down how to evaluate Figma stock, what metri...
Synopsys is set to report its fiscal Q1 results after the bell today. Traders will watch for IP-unit performance and ...
Dubai is poised to test a new era of urban travel with Uber and Joby Aviation. This article breaks down what the 2026...
Artificial intelligence is reshaping data centers, elevating power needs and cooling complexity. This article explain...
Zillow's latest forecast for 2026 hints at a shifting housing landscape. This guide breaks down what it means for mor...
A straightforward, discipline-driven strategy suggests buying three Vanguard index funds to potentially outperform th...
Vertiv rode a powerful wave in February as AI-driven data-center demand accelerated and the company highlighted durab...